Clinical trial
The Role of De Novo Lipogenesis in Regulation of Insulin Sensitivity in Adipose Tissue in Obese
NCT04260542 is registered in ClinicalTrials.gov with Charles University, Czech Republic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of De Novo Lipogenesis in Regulation of Insulin Sensitivity in Adipose Tissue in Obese
- Lead sponsor
- Charles University, Czech Republic
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 1, 2019
- Completion date
- March 11, 2022
- Enrollment
- 66 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.